Blog
Discover How Helix is Changing the World of Healthcare
Resources Hub
The Latest Content From Helix
Recent Blog Posts
View All Blog PostsRecent Press Releases
View All Press ReleasesPress Releases
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care
Press Releases
Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments
Press Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Recent Videos
View All Videos
Recent Published Research
View All Published Research1
Published Research
From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence
2
Published Research
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort
3
Published Research
Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project
4
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
5
Published Research
Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions
The Latest Content From Helix
Recent Blog Posts
View All Blog PostsBlog
Partnering with Veracyte to Deliver More Complete Genomic Insights in Prostate Cancer Care
Blog
From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.
By James Lu, MD, PhD, CEO and Co-Founder of Helix
Blog
Understanding Hidden Heart Risk: How Genetics Can Inform Your Lp(a) Levels
Blog
GLP-1 Spending Is Spiraling — But There's a Smarter Way Forward
Recent Press Releases
View All Press ReleasesPress Releases
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care
Press Releases
Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments
Press Releases
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Recent Videos
View All VideosRecent Published Research
View All Published Research1
Published Research
From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World Evidence
2
Published Research
Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort
3
Published Research
Chatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering Project
4
Published Research
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60
5
Published Research
